Von Minckwitz G, Huang CS, Mano MS, Loibl S, Mamounas EP, Untch M, Wolmark N, Rastogi P, Schneeweiss A, Redondo A, Fischer HH, Jacot W, Conlin AK, Arce-Salinas C, Wapnir IL, Jackisch C, Digiovanna MP, Fasching P, Crown JP, Wuelfing P, Shao Z, Caremoli ER, Wu H, Lam LH, Tesarowski D, Smitt M, Douthwaite H, Singel SM, Geyer CE (2019)
Publication Type: Journal article
Publication year: 2019
Book Volume: 380
Pages Range: 617-628
Journal Issue: 7
BACKGROUND
APA:
Von Minckwitz, G., Huang, C.-S., Mano, M.S., Loibl, S., Mamounas, E.P., Untch, M.,... Geyer, C.E. (2019). Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer. New England Journal of Medicine, 380(7), 617-628. https://doi.org/10.1056/NEJMoa1814017
MLA:
Von Minckwitz, G., et al. "Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer." New England Journal of Medicine 380.7 (2019): 617-628.
BibTeX: Download